The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...

On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, is no longer in short supply. The FDA allows ...

An icon in the shape of a lightning bolt ... their food products as a healthy snack alternative. The last time the FDA issued an update on the "healthy" label was three decades ago, according ...

The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly ... the drugs that many patients use, but the FDA said it would not take any action against ...

Although the eggs were initially recalled just five days after distribution on November 27, the FDA reclassified the recall to Class 1 – the agency’s highest alert level – on Friday.

The U.S. Food and Drug Administration (FDA) announced that eggs meet the agency's newly updated definition of "healthy.” The FDA created the new definition using current nutrition science and federal ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec ... patients who qualify and have no contraindications, tirzepatide ...

Califf made no mention of immediate plans to replace Bumpus in his email. President-elect Trump has nominated Martin Makary, a Johns Hopkins surgeon and author, to replace Califf as FDA head.

Nuvation Bio (NUVB) announced that the U.S. FDA has accepted the company’s NDA for taletrectinib, an investigational next-generation ROS1 tyrosine kinase inhibitor TKI , for the treatment of ...

The FDA is issuing multiple advisories for oysters and Manila clams that could be contaminated with Norovirus, a serious gastrointestinal illness. In the case of oysters from British Columbia ...